Researchers have been monitoring how COVID-19 vaccinations perform to determine whether booster shots will be needed, as variants of the novel coronavirus continue to mutate and spread. Now, the NIH announced they are beginning a Phase I/II clinical trial to test the safety and efficacy of different booster schedules.
[Genetic Engineering & Biotechnology News]